Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

boiron sa - artemisia eberraate - tm, d; tm, d - homöopathisch

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

boiron sa - artemisia eberraate - k30, d; lm/q1, d - homöopathisch

Canada - français - Health Canada

hoffmann-la roche limited - casirivimab; imdévimab - solution - 1332mg; 1332mg - casirivimab 1332mg; imdévimab 1332mg - monoclonal antibodies

Canada - français - Health Canada

hoffmann-la roche limited - casirivimab; imdévimab - solution - 300mg; 300mg - casirivimab 300mg; imdévimab 300mg - monoclonal antibodies

Union européenne - français - EMA (European Medicines Agency)

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - agents antinéoplasiques - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Union européenne - français - EMA (European Medicines Agency)

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - des sérums et immunoglobulines, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. voir les sections 4. 4 et 5.

Canada - français - Health Canada

astrazeneca canada inc - tixagévimab; cilgavimab - solution - 150mg; 150mg - tixagévimab 150mg; cilgavimab 150mg

Canada - français - Health Canada

gilead sciences canada inc - elvitegravir - comprimé - 85mg - elvitegravir 85mg - hiv integrase inhibitors

Canada - français - Health Canada

gilead sciences canada inc - elvitegravir - comprimé - 150mg - elvitegravir 150mg - hiv integrase inhibitors

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

allergopharma ag - pollinis allergeni extractum (ambrosia artemisiifolia) - pulver und lösungsmittel zur herstellung einer provokationstestlösung - praeparatio cryodesiccata: pollinis allergeni extractum (ambrosia artemisiifolia) 25000 u., mannitolum, pro vitro. solvens: natrii chloridum, natrii hydrogenocarbonas, phenolum, aqua q.s. ad solutionem pro 1 ml. - diagnostic de l'allergie - allergène: diagnostic